Birdwatch Archive

Birdwatch Note

2024-08-17 15:43:21 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m

Written by BBA35342C23D75B08E8CEA08D3FEEB4B960F974291B2586A7FB7C49141149A6B
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824828982170202460

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1824834408672583923
  • noteId - 1824834408672583923
  • participantId -
  • noteAuthorParticipantId - BBA35342C23D75B08E8CEA08D3FEEB4B960F974291B2586A7FB7C49141149A6B Participant Details
  • createdAtMillis - 1723909401468
  • tweetId - 1824828982170202460
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m

Note Ratings

rated at rated by
2024-08-20 03:53:08 -0500 Rating Details
2024-08-18 16:07:39 -0500 Rating Details
2024-08-18 13:11:53 -0500 Rating Details
2024-08-18 12:03:07 -0500 Rating Details
2024-08-18 09:39:59 -0500 Rating Details
2024-08-18 09:21:05 -0500 Rating Details
2024-08-18 09:00:28 -0500 Rating Details
2024-08-18 08:55:16 -0500 Rating Details
2024-08-18 08:31:45 -0500 Rating Details
2024-08-18 04:12:54 -0500 Rating Details
2024-08-18 03:44:30 -0500 Rating Details
2024-08-18 03:09:52 -0500 Rating Details
2024-08-18 02:05:43 -0500 Rating Details
2024-08-18 02:03:52 -0500 Rating Details
2024-08-18 01:12:48 -0500 Rating Details
2024-08-18 00:51:46 -0500 Rating Details
2024-08-18 00:27:08 -0500 Rating Details
2024-08-17 17:57:17 -0500 Rating Details
2024-08-17 17:01:44 -0500 Rating Details
2024-08-17 16:02:54 -0500 Rating Details
2024-08-17 15:49:18 -0500 Rating Details
2024-08-17 15:17:25 -0500 Rating Details
2024-08-17 15:14:46 -0500 Rating Details
2024-08-17 15:12:43 -0500 Rating Details
2024-08-17 14:32:40 -0500 Rating Details
2024-08-17 14:22:02 -0500 Rating Details
2024-08-17 14:13:00 -0500 Rating Details
2024-08-17 14:03:00 -0500 Rating Details
2024-08-17 13:49:25 -0500 Rating Details
2024-08-17 13:44:39 -0500 Rating Details
2024-08-17 13:41:09 -0500 Rating Details
2024-08-17 13:19:04 -0500 Rating Details
2024-08-17 13:11:12 -0500 Rating Details
2024-08-17 13:11:02 -0500 Rating Details
2024-08-17 12:55:12 -0500 Rating Details
2024-08-17 12:51:31 -0500 Rating Details
2024-08-17 12:40:47 -0500 Rating Details
2024-08-17 12:40:31 -0500 Rating Details
2024-08-17 12:38:10 -0500 Rating Details
2024-08-17 12:29:19 -0500 Rating Details
2024-08-17 12:22:52 -0500 Rating Details
2024-08-17 12:20:05 -0500 Rating Details
2024-08-17 12:13:05 -0500 Rating Details
2024-08-17 12:09:26 -0500 Rating Details
2024-08-17 12:07:52 -0500 Rating Details
2024-08-17 12:04:15 -0500 Rating Details
2024-08-17 11:56:38 -0500 Rating Details
2024-08-17 11:56:27 -0500 Rating Details
2024-08-17 11:54:21 -0500 Rating Details
2024-08-17 11:48:29 -0500 Rating Details
2024-08-17 11:45:29 -0500 Rating Details
2024-08-17 11:42:04 -0500 Rating Details
2024-08-17 11:41:49 -0500 Rating Details
2024-08-17 11:41:08 -0500 Rating Details
2024-08-17 11:39:35 -0500 Rating Details
2024-08-17 11:35:22 -0500 Rating Details
2024-08-17 11:35:19 -0500 Rating Details
2024-08-17 11:34:15 -0500 Rating Details
2024-08-17 11:29:05 -0500 Rating Details
2024-08-17 11:27:36 -0500 Rating Details
2024-08-17 11:25:18 -0500 Rating Details
2024-08-17 11:24:10 -0500 Rating Details
2024-08-17 11:23:52 -0500 Rating Details
2024-08-17 11:23:21 -0500 Rating Details
2024-08-17 11:21:08 -0500 Rating Details
2024-08-17 10:59:03 -0500 Rating Details
2024-08-17 10:54:57 -0500 Rating Details
2024-08-17 10:53:13 -0500 Rating Details
2024-08-17 10:48:12 -0500 Rating Details
2024-08-18 15:39:15 -0500 Rating Details
2024-08-18 07:33:04 -0500 Rating Details
2024-08-18 03:17:21 -0500 Rating Details
2024-08-17 18:23:59 -0500 Rating Details
2024-08-17 17:35:23 -0500 Rating Details
2024-08-17 17:13:44 -0500 Rating Details
2024-08-17 16:04:12 -0500 Rating Details
2024-08-17 15:13:10 -0500 Rating Details
2024-08-17 14:36:24 -0500 Rating Details
2024-08-17 13:40:00 -0500 Rating Details
2024-08-17 13:08:37 -0500 Rating Details
2024-08-17 12:54:16 -0500 Rating Details
2024-08-17 12:53:05 -0500 Rating Details
2024-08-17 12:42:49 -0500 Rating Details
2024-08-17 12:39:17 -0500 Rating Details
2024-08-17 11:44:12 -0500 Rating Details
2024-08-17 11:25:01 -0500 Rating Details
2024-08-17 11:20:16 -0500 Rating Details
2024-08-17 11:03:01 -0500 Rating Details
2024-09-11 19:03:55 -0500 Rating Details